Using rapid atrial pacing to predict the need for pacemaker implantation after TAVI
Official title: Rapid Atrial Pacing After TAVI as a Predictor of Permanent Pacemaker Implantation
Run by National and Kapodistrian University of Athens · NCT06189976 · Data updated 2026-11-12
This study is testing if a quick heart pacing method can help doctors predict which patients will need a permanent pacemaker after getting a new heart valve.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | National and Kapodistrian University of Athens Academic / other |
| Locations | 2 sites (Brussels and 1 other locations) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | April 30, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | December 12, 2024 |
| Trial ID | NCT06189976 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who are undergoing TAVI for severe aortic stenosis and are in sinus rhythm.
✕Probably not a fit
Patients with ongoing infections, those who already have a permanent pacemaker, or those who develop significant atrioventricular block after TAVI may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of rapid atrial pacing (RAP) as a predictive tool for the necessity of permanent pacemaker implantation (PPI) following transcatheter aortic valve implantation (TAVI). The study aims to assess the atrioventricular conduction system through RAP using a temporary pacemaker lead, which could provide valuable insights into patient management post-TAVI. By evaluating patients undergoing TAVI for severe aortic stenosis, the trial seeks to establish a reliable method for identifying those at risk of requiring PPI. The findings could help refine clinical decision-making and improve patient outcomes.
Why it matters
Potential benefit: If successful, this study could lead to better risk stratification for patients undergoing TAVI, potentially reducing unnecessary pacemaker implantations.
How similar studies have gone: While the approach of using rapid atrial pacing is relatively novel, existing studies have indicated the importance of electrophysiological testing in predicting PPI post-TAVI.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults ≥18 years old. 2. Patient understands the purpose, the potential risks as well as benefits of the trial and is willing to participate in all parts of the follow-up. 3. Patient has given written consent to participate in the trial. 4. Patients undergoing TAVI as a treatment of severe aortic stenosis (AS). 5. Patient in sinus rhythm. 6. Patients planned for TAVI with utilization of temporary pacemaker electrode placement. Exclusion Criteria: 1. Ongoing infection, including active endocarditis. 2. Implanted permanent pacemaker and/or implantable cardioverter/defibrillator. 3. Patients developing persistent second or third degree atrioventricular block (AV) after TAVI. 4. Underlying rhythm other than sinus based on the surface ECG leads monitoring after TAVI. 5. Patients with second or third degree AV block identifyied on the screening pre-TAVI ECG. 6. Enrolment in another study that competes or interferes with this study. 7. Subject will not be able to comply with the follow-up requirements according to investigators' opinion. 8. Pregnant or breast-feeding females or females who intend to become pregnant during the time of the study.
Where it's running
-
CHU Saint-Pierre
Brussels, Belgium Recruiting -
Hippocration Hospital
Athens, Attica, Greece Recruiting
Study contacts
- Principal investigator: Leonidas Koliastasis — National and Kapodistrian University of Athens
- Study coordinator: Leonidas Koliastasis, MD, PhD
- Email: lkoliastasis@gmail.com
- Phone: +30 6974270752
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote monitoring for patients after heart valve replacement
This study tests if using remote monitoring can help patients who have had heart valve replacement recover better and go home sooner by catching any problems early.
-
KONECT RESILIA Aortic Valved Conduit real-world use in adults needing valve and ascending aorta replacement
This study tests how the KONECT RESILIA aortic valved conduit performs in adults needing aortic valve and ascending aorta replacement.
-
Savvywire versus standard LV guidewires during transfemoral TAVI
For people 50 and older having transfemoral TAVI, researchers will compare the Savvywire and standard LV guidewires to see if the Savvywire improves pacing and procedure-related blood flow.
-
EmStop Embolic Protection System for TAVR in Aortic Valve Stenosis
This study tests whether the EmStop protective device can safely capture and remove debris during transcatheter aortic valve replacement in adults with severe aortic valve stenosis.
-
Tracking progression and consequences of heart valve disease
This project will follow adults with moderate or worse valve disease to see if clinical tests and imaging can predict when their condition will get worse.
-
Using AI to improve planning for transcatheter heart valve procedures
This project uses AI to analyze CT and echo images to see if it can better predict outcomes for people who had transcatheter aortic, mitral, or tricuspid valve procedures.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.